Knowledge (XXG)

Category:Drugs for benign prostatic hyperplasia

Source 📝

219: 37: 30: 225: 23: 272: 317: 47: 60: 296: 178: 131: 244: 82: 378: 342: 185: 149: 15: 144: 354: 154: 169: 93: 372: 139: 236: 229: 51: 300: 276: 202: 78: 73: 68: 359: 159: 116: 121: 111: 106: 101: 260:
This category has the following 2 subcategories, out of 2 total.
330: 19: 213: 316:
The following 4 pages are in this category, out of 4 total.
313:
Pages in category "Drugs for benign prostatic hyperplasia"
226:
Anatomical Therapeutic Chemical Classification System
195: 168: 130: 92: 59: 31: 8: 224:This category reflects the organization of 38: 24: 16: 318:This list may not reflect recent changes 235:Generally, drugs outlined within the 7: 239:should be included in this category. 322: 293: 262: 254: 14: 217: 1: 48:benign prostatic hyperplasia 395: 273:5α-Reductase inhibitors 132:Steroidal antiandrogens 61:5α-Reductase inhibitors 247:for more information. 343:Gestonorone caproate 186:Saw palmetto extract 150:Gestonorone caproate 145:Delmadinone acetate 355:Osaterone acetate 252: 251: 248: 211: 210: 155:Osaterone acetate 386: 302: 295: 278: 242: 221: 220: 214: 179:Pygeum africanum 94:Alpha-1 blockers 40: 33: 26: 17: 394: 393: 389: 388: 387: 385: 384: 383: 369: 368: 367: 366: 365: 364: 347: 335: 310: 309: 308: 307: 304: 303: 292: 283: 280: 279: 253: 241: 233: 218: 212: 207: 191: 170:Herbal products 164: 126: 88: 55: 44: 12: 11: 5: 392: 390: 382: 381: 371: 370: 363: 362: 357: 351: 348: 346: 345: 339: 336: 334: 333: 327: 324: 323: 314: 311: 306: 305: 297:Alpha blockers 291: 290: 287: 284: 282: 281: 271: 270: 267: 264: 263: 258: 255: 250: 249: 222: 209: 208: 206: 205: 199: 197: 193: 192: 190: 189: 182: 174: 172: 166: 165: 163: 162: 157: 152: 147: 142: 136: 134: 128: 127: 125: 124: 119: 114: 109: 104: 98: 96: 90: 89: 87: 86: 76: 71: 65: 63: 57: 56: 46:Drugs used in 45: 43: 42: 35: 28: 20: 13: 10: 9: 6: 4: 3: 2: 391: 380: 377: 376: 374: 361: 358: 356: 353: 352: 349: 344: 341: 340: 337: 332: 329: 328: 325: 321: 319: 312: 298: 294: 289: 288: 285: 274: 269: 268: 265: 261: 257:Subcategories 256: 246: 240: 238: 237:ATC code G04C 231: 227: 223: 216: 215: 204: 201: 200: 198: 194: 188: 187: 183: 181: 180: 176: 175: 173: 171: 167: 161: 158: 156: 153: 151: 148: 146: 143: 141: 140:Allylestrenol 138: 137: 135: 133: 129: 123: 120: 118: 115: 113: 110: 108: 105: 103: 100: 99: 97: 95: 91: 84: 80: 77: 75: 72: 70: 67: 66: 64: 62: 58: 53: 49: 41: 36: 34: 29: 27: 22: 21: 18: 315: 259: 245:WP:PHARM:CAT 234: 184: 177: 379:Urologicals 301:(2 C, 14 P) 243:Please see 228: code 203:Mepartricin 79:Finasteride 74:Epristeride 69:Dutasteride 360:Oxendolone 160:Oxendolone 117:Tamsulosin 83:+tadalafil 122:Terazosin 112:Silodosin 107:Doxazosin 102:Alfuzosin 373:Category 277:(39 P) 196:Others 331:BOMT 230:G04C 52:G04C 266:0–9 375:: 320:. 299:‎ 275:‎ 350:O 338:G 326:B 286:A 232:. 85:) 81:( 54:) 50:( 39:e 32:t 25:v

Index

v
t
e
benign prostatic hyperplasia
G04C
5α-Reductase inhibitors
Dutasteride
Epristeride
Finasteride
+tadalafil
Alpha-1 blockers
Alfuzosin
Doxazosin
Silodosin
Tamsulosin
Terazosin
Steroidal antiandrogens
Allylestrenol
Delmadinone acetate
Gestonorone caproate
Osaterone acetate
Oxendolone
Herbal products
Pygeum africanum
Saw palmetto extract
Mepartricin
Anatomical Therapeutic Chemical Classification System
G04C
ATC code G04C
WP:PHARM:CAT

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.